Skinvisible, Inc.

Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a R&D pharmaceutical company that develops enhanced dermatology products and improves their life cycle management by revitalizing their patents with the Company’s polymer

delivery system called Invisicare®.
Invisicare is a delivery system developed to bind active ingredients on the skin for four hours or more and resist wash-off along with enhancing the delivery of the ingredients.
Additionally, new patents can be issued for products which have been developed or re-formulated with Invisicare. The Company has developed a portfolio of topical skincare products using Invisicare for the dermatology and cosmeceutical industries.

Aligned with its R&D focus, Skinvisible's primary objective is to license its patented technology and dermatology products containing Invisicare, to manufacturers and marketers of prescription and over-the-counter products in the dermatology, cosmetic and skincare markets.

Latest News:
The Analyst Report

February 25, 2008

July 21, 2008

July 29, 2008
Skinvisible Offers 8 Hour Photostablity for Parsol 1789 - UVA Sunscreen with Invisicare Available For International Licensing

June 11, 2008
Skinvisible Appoints New Vice President of Business Development & Marketing - Strategic Plan for Invisicare Strengthens

June 3, 2008
Skinvisible Patent Granted in Australia - Invisicare Patents Continue to be Granted Globally